Article Information
History
- November 17, 2021.
Article Versions
- You are currently viewing Version 1 of this article (November 17, 2021 - 09:58).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bárbara M Schultz1,#,
- Felipe Melo-González1,#,
- Luisa F Duarte1,#,
- Nicolás MS Gálvez1,#,
- Gaspar A Pacheco1,#,
- Jorge A Soto1,#,
- Roslye V Berríos-Rojas1,2,
- Liliana A González1,2,
- Daniela Moreno-Tapia1,2,
- Daniela Rivera-Pérez1,2,
- Guillermo Hoppe-Elsholz1,2,
- Carolina Iturriaga3,
- Mariana Ríos1,2,
- Omar P Vallejos1,2,
- Marcela Urzua3,
- Yaneisi Vázquez1,2,
- María S Navarrete4,
- Álvaro Rojas4,
- Daniela Weiskopf5,
- Alessandro Sette5,6,
- Gang Zeng7,
- Weining Meng7,
- CoronaVac03CL Study Group,
- José V González-Aramundiz8,
- Pablo A González1,2,
- Katia Abarca1,3,
- Alexis M Kalergis*,1,2,9 and
- Susan M Bueno*,1,2
- 1Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- 2Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
- 3Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
- 4Departamento de Enfermedades Infecciosas del Adulto, División de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
- 5Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
- 6Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA
- 7Sinovac Biotech, Beijing, China
- 8Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile
- 9Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
- ↵*Corresponding authors. email: sbueno{at}bio.puc.cl
↵# These authors contributed equally to this work.
Posted November 17, 2021.
A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2
